A scientific study has revealed their proximity to discovering a treatment and a blood test to detect those at risk of long-term injuries from the coronavirus.

The British newspaper The Guardian reported that a team from the University of Oxford has been following about 2000 coronavirus survivors from the time of their infection until a period after recovery, to understand the chemicals present in the body associated with long-term injuries.

The team found that two proteins are linked to the persistence of symptoms after recovery, namely d-dimer protein and fibrinogen protein, both of which can be detected through a blood test.

The team explained that these proteins cause types of clots in the lungs and the brain, which explains that the symptoms of long-term COVID are respiratory, caused by d-dimer, or cognitive fog, caused by fibrinogen.

The results of the study indicate that clot medications may become a treatment for long COVID symptoms, but only after the necessary trials are conducted.